Literature DB >> 1804971

Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion.

K M Pumford1, G Leng, J A Russell.   

Abstract

1. The effects of acute i.v. administration of morphine on putative oxytocin neurones of the supraoptic nucleus were studied in urethane-anaesthetized female rats which had been exposed to i.c.v. infusion of morphine (up to 50 micrograms h-1) or vehicle for 5 days. 2. In vehicle-infused rats, i.v. morphine inhibited the spontaneous activity of six out of seven putative oxytocin neurones. Increasing doses of morphine were given, from 1 microgram kg-1 to 5 mg kg-1. The median cumulative threshold dose to produce significant inhibition was 20 micrograms kg-1 (seven cells in six rats); six out of seven cells were inhibited at 161 micrograms kg-1. The highest doses tested inhibited by approximately 90% (excluding one unaffected cell). Inhibition was fully reversed by i.v. naloxone without overshoot, indicating a lack of acute dependence. 3. Injection of morphine i.c.v. inhibited firing at doses that were ineffective by i.v. injection and the effects of i.c.v. morphine were reversed by i.v. naloxone. 4. Acute morphine (500 micrograms kg-1 i.v.) reduced the plasma concentration of oxytocin, measured after 15 min by specific radioimmunoassay, by 34% (n = 14). 5. In lactating rats i.c.v. injection of morphine (1-2 micrograms) inhibited the activity of supraoptic neurones identified as oxytocinergic by their responses to suckling. 6. In seventeen rats infused with i.c.v. morphine the initial firing rate of twenty-eight spontaneously active, non-phasic neurones was significantly less, by 24%, than thirty-four similar cells in control rats, indicating incomplete tolerance to i.c.v. morphine. Morphine (up to 161 micrograms kg-1 given i.v.) inhibited none of nine active non-phasic neurones (P less than 0.01 compared to control rats), but at higher doses inhibited four of nine cells; the overall median threshold cumulative dose (1660 micrograms kg-1) was significantly greater than in vehicle-infused controls, indicating tolerance to i.v. morphine. In contrast with control rats, some cells (5/9) were modestly excited by low doses of morphine. Naloxone (5 mg kg-1 i.v.) produced withdrawal excitation: the firing rate of putative oxytocin neurones increased to approximately 260% of the pre-i.v. morphine value, indicating dependence in mechanisms regulating the firing rate of these neurones. 7. In morphine-infused rats, the basal firing rate of nineteen phasically active, putative vasopressin supraoptic neurones was not different in nineteen phasic cells in controls (6.4 +/- 0.7 vs. 4.2 +/- 0.6 Hz). 8. Thus morphine potently inhibits the firing of magnocellular oxytocin neurones in the female rat, inhibiting oxytocin secretion. Morphine tolerance and dependence develop during i.c.v. infusion of morphine for 5 days. Similar tolerance to and dependence upon endogenous opioids during pregnancy may be important in the preparation of oxytocin neurones for parturition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804971      PMCID: PMC1180161          DOI: 10.1113/jphysiol.1991.sp018717

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.

Authors:  N A Sharif; J Hughes
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

Review 2.  The role of the AV3V region in the control of magnocellular oxytocin neurons.

Authors:  J A Russell; R E Blackburn; G Leng
Journal:  Brain Res Bull       Date:  1988-06       Impact factor: 4.077

3.  Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa.

Authors:  M Herkenham; K C Rice; A E Jacobson; R B Rothman
Journal:  Brain Res       Date:  1986-09-24       Impact factor: 3.252

Review 4.  Anatomy of CNS opioid receptors.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

5.  Down regulation of hypothalamic proopiomelanocortin system during morphine tolerance.

Authors:  I Mocchetti; E Costa
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

Review 6.  The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors.

Authors:  H W Kosterlitz
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-07-22

7.  Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study.

Authors:  L S Brady; M Herkenham; J B Long; R B Rothman
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

8.  The influence of morphine and naloxone on plasma oxytocin concentration in the rat.

Authors:  S Grell; J D Christensen; B Fjalland
Journal:  Pharmacol Toxicol       Date:  1988-10

9.  Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Does acute, intense stimulation of oxytocin neurones in the supraoptic nucleus increase their content of oxytocin mRNA?

Authors:  B E Sumner; M Kawata; J A Russell
Journal:  Brain Res       Date:  1989-06-12       Impact factor: 3.252

View more
  15 in total

1.  Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.

Authors:  C H Brown; G Munro; N P Murphy; G Leng; J A Russell
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

3.  Apamin increases post-spike excitability of supraoptic nucleus neurons in anaesthetized morphine-naïve rats and morphine-dependent rats: consequences for morphine withdrawal excitation.

Authors:  Philip M Bull; John A Russell; Victoria Scott; Colin H Brown
Journal:  Exp Brain Res       Date:  2011-06-14       Impact factor: 1.972

4.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

5.  A pertussis toxin-sensitive G protein mediates inhibition by morphine of spontaneous electrical activity of oxytocin neurones in anaesthetized rats.

Authors:  K M Pumford; G Leng; J A Russell
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 6.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

7.  Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.

Authors:  J A Russell; J E Coombes; G Leng; R J Bicknell
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

8.  Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.

Authors:  K M Pumford; J A Russell; G Leng
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.

Authors:  C H Brown; M Ludwig; G Leng
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

10.  Effects of the kappa-opioid agonist U50,488 on parturition in rats.

Authors:  A J Douglas; G Clarke; S J MacMillan; P M Bull; I Neumann; S A Way; D M Wright; B G McGrory; J A Russell
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.